These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9786066)

  • 1. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system.
    Wang L; Sun J; Li L; Mears D; Horvat M; Sheil AG
    Cell Transplant; 1998; 7(5):459-68. PubMed ID: 9786066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of C3A cell metabolism for usage in bioartificial liver support systems.
    Filippi C; Keatch SA; Rangar D; Nelson LJ; Hayes PC; Plevris JN
    J Hepatol; 2004 Oct; 41(4):599-605. PubMed ID: 15464240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia.
    Mavri-Damelin D; Damelin LH; Eaton S; Rees M; Selden C; Hodgson HJ
    Biotechnol Bioeng; 2008 Feb; 99(3):644-51. PubMed ID: 17680661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma.
    Li ZH; Xie ZY; Ouyang XX; Huang KZ; Yu XP; Zhao YL; Zhang YH; Zhu DH; Yu J; Li LJ
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):129-137. PubMed ID: 31704080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
    van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
    Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of multivariables during porcine liver digestion to improve hepatocyte yield and viability for use in bioartificial liver support systems.
    Wang L; Sun J; Wang C; Woodman K; Li L; Wu L; Harbour C; Johnston B; Shi L; Horvat M; Koutalistras N; Luo X; Watson J; Sheil AG
    Cell Transplant; 2000; 9(3):329-36. PubMed ID: 10972332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.
    Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R
    J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
    Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T
    Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the methods for assessment of hepatocyte P450IA1, P450IIB1, viability and proliferation in bioartificial liver support system matrices.
    Wang L; Sun J; Li L; Koutalistras N; Wang C; Sheil R
    Transplant Proc; 1997; 29(1-2):395-6. PubMed ID: 9123053
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure.
    Chen XP; Xue YL; Li XJ; Zhang ZY; Li YL; Huang ZQ
    World J Gastroenterol; 2001 Oct; 7(5):706-9. PubMed ID: 11819859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
    van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device - the hybrid-MDS.
    Harm S; Stroble K; Hartmann J; Falkenhagen D
    Int J Artif Organs; 2009 Nov; 32(11):769-78. PubMed ID: 20020408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models.
    Donato MT; Castell JV; Gómez-Lechón MJ
    J Hepatol; 1999 Sep; 31(3):542-9. PubMed ID: 10488716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anticoagulants on porcine hepatocytes in vitro: implications in the porcine hepatocyte-based bioartificial liver.
    Eguchi S; Kawazoe Y; Sugiyama N; Kawashita Y; Fujioka H; Furui J; Kanematsu T
    Int J Artif Organs; 1999 May; 22(5):329-33. PubMed ID: 10467932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver.
    Nedredal GI; Elvevold K; Ytrebø LM; Fuskevåg OM; Pettersen I; Bertheussen K; Langbakk B; Smedsrød B; Revhaug A
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G75-83. PubMed ID: 17363468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver.
    Joly A; Desjardins JF; Fremond B; Desille M; Campion JP; Malledant Y; Lebreton Y; Semana G; Edwards-Levy F; Levy MC; Clement B
    Transplantation; 1997 Mar; 63(6):795-803. PubMed ID: 9089217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
    Tang NH; Wang XQ; Li XJ; Chen YL
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fulminant hepatic failure porcine plasma supplemented with essential components on encapsulated rat hepatocyte spheroids.
    Lee JH; Lee DH; Park JK; Kim SK; Kwon CH; Lee SK
    Transplant Proc; 2012 May; 44(4):1009-11. PubMed ID: 22564611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.